MX9300602A - Analogos de fenilalanina de bombesina. - Google Patents

Analogos de fenilalanina de bombesina.

Info

Publication number
MX9300602A
MX9300602A MX9300602A MX9300602A MX9300602A MX 9300602 A MX9300602 A MX 9300602A MX 9300602 A MX9300602 A MX 9300602A MX 9300602 A MX9300602 A MX 9300602A MX 9300602 A MX9300602 A MX 9300602A
Authority
MX
Mexico
Prior art keywords
bombesin
phenylalanine analogs
phenylalanine
derivatives
agonist
Prior art date
Application number
MX9300602A
Other languages
English (en)
Inventor
Judson V Edwards
Bradford O Fanger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of MX9300602A publication Critical patent/MX9300602A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57572Gastrin releasing peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se describen agonistas y antagonistas de bombesina, los cuales son derivados modificados de fenilalanina que poseen bombesina, que se presentan naturalmente. Las actividades agonistas y antagonistas se confirman empleando ensayos bioquímicos y de aglutinación competitiva convencional, así como pruebas fisiológicas, convencionales, y el uso de estos derivados en una variedad de condiciones.
MX9300602A 1992-02-07 1993-02-04 Analogos de fenilalanina de bombesina. MX9300602A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83383492A 1992-02-07 1992-02-07

Publications (1)

Publication Number Publication Date
MX9300602A true MX9300602A (es) 1993-08-01

Family

ID=25265391

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300602A MX9300602A (es) 1992-02-07 1993-02-04 Analogos de fenilalanina de bombesina.

Country Status (14)

Country Link
US (1) US5428018A (es)
EP (1) EP0626973A1 (es)
JP (1) JPH07505865A (es)
KR (1) KR950700325A (es)
AU (1) AU668909B2 (es)
CA (1) CA2129032A1 (es)
FI (1) FI943638A (es)
HU (1) HUT71585A (es)
IL (1) IL104621A0 (es)
MX (1) MX9300602A (es)
NO (1) NO942919L (es)
NZ (1) NZ246815A (es)
WO (1) WO1993016105A1 (es)
ZA (1) ZA93716B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US7078413B2 (en) 1996-04-19 2006-07-18 Wisconsin Alumni Research Foundation Compositions and methods of use for a bombesin peptide
UA65549C2 (uk) 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
DE69840647D1 (de) * 1997-04-22 2009-04-23 Curator Of The University Of M Konjugate aus peptiden, die liganden von gastrinrezeptoren sind
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) * 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
ATE435035T1 (de) * 2003-01-13 2009-07-15 Bracco Imaging Spa Verbesserte linker für radiopharmazeutische verbindungen
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
IL312551A (en) 2012-09-25 2024-07-01 Advanced Accelerator Applications Usa Inc GRPR antagonists for the detection, diagnosis and treatment of GRPR-positive cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
US4631270A (en) * 1978-11-20 1986-12-23 Research Corporation Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
ATE16495T1 (de) * 1981-06-22 1985-11-15 Ici Plc Peptide und pseudopeptide, die zwei substituenten am n-terminus aufweisen.
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
EP0313158A3 (en) * 1987-10-23 1990-08-22 Merck & Co. Inc. Gastrin releasing peptide antagonist
US5047502A (en) * 1987-10-23 1991-09-10 Merck And Co., Inc. Gastrin releasing peptide antagonist
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8806644D0 (en) * 1988-03-21 1988-04-20 Imp Cancer Res Tech Neuropeptide antagonists
GB8808768D0 (en) * 1988-04-14 1988-05-18 Erba Carlo Spa Peptide ligands for bombesin receptors
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
GR1000608B (el) * 1988-07-21 1992-08-31 Erba Carlo Spa Μεθοδος για την παρασκευη ανταγωνιστων bombesin.
HU208439B (en) * 1988-10-14 1993-10-28 Univ Tulane Process for producing pharmaceutical peptides
US5028692A (en) * 1989-04-25 1991-07-02 Merck & Co., Inc. Gastrin releasing peptide antagonist
KR920701242A (ko) * 1989-11-06 1992-08-11 원본미기재 환원된 비가역성 봄베신 길항제
NZ236114A (en) * 1989-11-22 1993-04-28 Merrell Dow Pharma Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions
JPH05506862A (ja) * 1990-05-09 1993-10-07 ジ・アドミニストレイターズ・オブ・ザ・トゥーラン・エデュケイショナル・ファンド 環状および鎖状の治療用ペプチド
ZA915740B (en) * 1990-07-26 1992-05-27 Merrell Dow Pharma Peptides
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists

Also Published As

Publication number Publication date
CA2129032A1 (en) 1993-08-19
NO942919D0 (es) 1994-08-05
FI943638A0 (fi) 1994-08-05
FI943638A (fi) 1994-08-05
WO1993016105A1 (en) 1993-08-19
NO942919L (no) 1994-08-05
HUT71585A (en) 1995-12-28
IL104621A0 (en) 1993-06-10
JPH07505865A (ja) 1995-06-29
AU3439993A (en) 1993-09-03
EP0626973A1 (en) 1994-12-07
KR950700325A (ko) 1995-01-16
HU9402285D0 (en) 1994-10-28
US5428018A (en) 1995-06-27
AU668909B2 (en) 1996-05-23
NZ246815A (en) 1996-02-27
ZA93716B (en) 1993-09-01

Similar Documents

Publication Publication Date Title
ES2175350T3 (es) Compuestos triciclicos que tienen afinidad de union a receptores de melatonina, su produccion y uso.
MX9300602A (es) Analogos de fenilalanina de bombesina.
BR9206237A (pt) Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1.
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
ES2141913T3 (es) Agonistas y antagonistas de los receptores de la adenosina a1.
ATE106401T1 (de) Benzodiazepin-analoge.
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
GR1001129B (el) Ανταγωνιστες ccκ αναλογου αμινοξεος.
ES2172535T3 (es) Antagonistas de los receptores de la endotelina.
BR0007864A (pt) Composto, e, uso de um composto
AR021596A1 (es) Compuestos que inhiben la procolageno c-proteinasa.
ES2180041T3 (es) Derivados de 5-oxido de piridazino(4,5-b)quinoleina, su preparacion y su uso como antagonistas de glicina.
EA200001039A1 (ru) Кальцилитические соединения
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
EA200300629A1 (ru) Конденсированные производные пурина как антагонисты рецепторов аденозина a
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
EA200500830A1 (ru) Производные имидазохинолина в качестве лигандов аденозиновых a3 рецепторов
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
ATE198202T1 (de) Fibrinogen receptor antagonisten
AR001813A1 (es) Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen
ES2057024T3 (es) Antagonistas de la neuroquinina a.
ES2084627T3 (es) Antagonistas de neuroquinina ciclica.
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
EA200000197A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
DK0552712T3 (da) 8-(1-aminocycloalkyl)1,3-dialkylxanthinderivater som antagonister for adenosinreceptorer